Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents | Zendy

Jeffrey J. Popma | Zendy; Laura Mauri | Zendy; Charles O’Shaughnessy | Zendy; Paul Overlie | Zendy; Brent McLaurin | Zendy; Alexandra Almonacid | Zendy; Ajay J. Kirtane | Zendy; Martin B. Leon | Zendy

Open Access

Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents

Author(s) -

Jeffrey J. Popma,

Laura Mauri,

Charles O’Shaughnessy,

Paul Overlie,

Brent McLaurin,

Alexandra Almonacid,

Ajay J. Kirtane,

Martin B. Leon

Publication year - 2009

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.108.832048

Subject(s) - occlusion , medicine , myocardial infarction , stent , cardiology

Myocardial infarction (MI) after drug-eluting stent placement has been associated with an unfavorable late prognosis. Although the etiology of periprocedural MI is multifactorial, sidebranch occlusion may be an important contributing factor. We sought to identify the incidence of sidebranch occlusion during zotarolimus-eluting stent (ZES) and paclitaxel-eluting stent (PES) placement and to relate sidebranch occlusion to the occurrence of periprocedural MI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research